2021-01-11,Delcath Systems to Present at the H.C. Wainwright Virtual BioConnect Conference
2020-12-11,Delcath Systems Announces Completion of Underwritten Public Offering
2020-12-09,Delcath Systems Announces Pricing of Public Offering of Common Stock
2020-12-08,Delcath Systems Announces Proposed Public Offering of Common Stock
2020-12-07,"Kevin Muir Joins Delcath Systems, Inc. as VP, Commercial Operations"
2020-11-11,"Delcath Systems, Inc. Announces Third Quarter 2020 Results"
2020-11-02,"Delcath Systems, Inc. to Participate in Oppenheimer Fall MedTech Summit on Thursday, November 12, 2020"
2020-11-02,Delcath Schedules Conference Call to Report 2020 Third Quarter Financial Results
2020-10-29,"Delcath Systems Announces a KOL Call on November 5, 2020 to discuss the Results of a Prospective Phase II Study in Patients with Metastatic Ocular Melanoma"
2020-10-01,Delcath Strengthens Executive Team with Appointment of Gerard Michel as Chief Executive Officer
2020-09-28,"Encode Ideas, L.P. to Host Key Opinion Leader Conference Call with Dr. Jonathan Zager, Principal Investigator for Delcath System's Phase 3 FOCUS Study"
2020-09-10,"Delcath Systems, Inc. to Participate in Upcoming Virtual Investor Conferences"
2020-09-02,LD Micro 360 Companies Set to Present this Week.
2020-08-25,"Delcath to Present at the LD Micro 500 Virtual Investor Conference on Tuesday, September 1, 2020 at 3:00pm ET"
2020-08-13,"Delcath Systems, Inc. Announces Second Quarter 2020 Results"
2020-08-06,Delcath Schedules Conference Call to Report 2020 Second Quarter Financial Results
2020-08-05,LD Micro - Announces Preliminary List of Presenters for the LD-500
2020-08-03,Delcath to Present at Canaccord Genuity 40th Annual Growth Conference
2020-05-26,Delcath Announces Leadership Transition
2020-05-19,"Encode Ideas, L.P. Announces the Initiation of Research Coverage on Delcath Systems, Inc."
2020-05-15,Delcath Announces First Quarter 2020 Results
2020-05-05,Delcath Systems Closes $22.0 Million Public Offering of Common Stock
2020-05-01,Delcath Systems Announces Pricing of $22 Million Public Offering and Uplisting to the Nasdaq Capital Market
2020-02-19,Delcath Systems Elects Seasoned Finance and Capital Markets Executive Elizabeth Czerepak to its Board of Directors
2020-01-13,Delcath Completes Enrollment in its United States Registration Pivotal Trial (FOCUS) Investigating Melphalan/HDS in the Treatment of Patients with Unresectable Hepatic-Dominant Ocular Melanoma
2019-12-19,"Delcath Systems Announces 1-for-700 Reverse Stock Split to be Effective on December 24, 2019"
2019-12-03,"Delcath Systems to Present at the 12th Annual LD Micro Main Event on December 10, 2019"
2019-10-22,Delcath Systems Announces Postponement of Reverse Stock Split
2019-10-18,Delcath Systems Announces Ratio for Reverse Stock Split
2019-10-15,"MicroCap Rodeo - Investor Conference Lineup for October 15 and 16, 2019"
2019-10-08,Delcath Systems to Present at the MicroCap Rodeo Investor Conference
2019-09-23,Delcath Systems to Participate in Upcoming Investor Conferences
